Art

J-GLOBAL ID：201802242320593547   Reference number：18A1141155

PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective

PD-1,PD-L1(B7-H1)および腫瘍部位免疫調節療法:歴史的展望【JST・京大機械翻訳】

Author (9)： Wang Jun (Yale University School of Medicine, New Haven, USA) ,  Yuan Ruirong (Veterans Health Administration Medical Center, East Orange, USA) ,  Yuan Ruirong (The Chinese American Hematologist and Oncologist Network (CAHON), Scarsdale, USA) ,  Song Wenru (The Chinese American Hematologist and Oncologist Network (CAHON), Scarsdale, USA) ,  Sun Jingwei (Yale University School of Medicine, New Haven, USA) ,  Liu Delong (The Chinese American Hematologist and Oncologist Network (CAHON), Scarsdale, USA) ,  Liu Delong (New York Medical College, Valhalla, USA) ,  Li Zihai (The Chinese American Hematologist and Oncologist Network (CAHON), Scarsdale, USA) ,  Li Zihai (Medical University of South Carolina, Charleston, USA)
Material： Journal of Hematology & Oncology (Web)
Volume： 10  Issue： 1  Page： 34  Publication year： 2017 
JST Material Number： U7517A  ISSN： 1756-8722  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： The current success of targete...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1141155&from=J-GLOBAL&jstjournalNo=U7517A") }}

Thesaurus term： *therapy ,  ontology ,  immunotherapy ,  computer programming ,  network ,  protein ,  excitation(physics) ,  semen ,  cytotoxic T cell
Semi thesaurus term： チェックポイント ,  CTLA-4抗原 ,  慢性化 ,  中国人 ,  癌免疫療法 ,  *免疫修飾 , 【Automatic Indexing@JST】

Author keywords (10)： B7-H1 ,  PD-L1 ,  PD-1 ,  CTLA-4 ,  CD28 ,  immune checkpoint ,  immunotherapy ,  immuno-oncology ,  T cells ,  tumor-site immune modulation therapy

JST classification (2)： Immunotherapy for tumors  (GE03035B) ,  Tumor immunity  (ED03040A)

Reference (95)：

• Cancer Immunother Sci; Breakthrough of the year 2013; J Couzin-Frankel; 342; 6165; 2013; 1432-1433; CR1;
• Science; Immunotherapy: it takes a village; D Pardoll; 344; 6180; 2014; 149; 10.1126/science.344.6180.149-a; CR2;
• J Clin Invest; Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future; L Chen, X Han; 125; 9; 2015; 3384-3391; 10.1172/JCI80011; CR3;
• Sci Transl Med; PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations; W Zou, JD Wolchok, L Chen; 8; 328; 2016; 328rv324; 10.1126/scitranslmed.aad7118; CR4;
• Cancer J; From the guest editor: Tumor site immune modulation therapy; L Chen; 20; 4; 2014; 254-255; 10.1097/PPO.0000000000000062; CR5;

Terms in the title (8)： PD-1 ,  PD-L1 ,  B7-H1 ,  腫瘍部位 ,  免疫調節 ,  療法 ,  歴史 ,  展望